Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1180209.RAfSg6JwldkfU3k7LbeHdVxevFZnM9ftLxUBC9hJTHpVc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1180209.RAfSg6JwldkfU3k7LbeHdVxevFZnM9ftLxUBC9hJTHpVc130_assertion type Assertion NP1180209.RAfSg6JwldkfU3k7LbeHdVxevFZnM9ftLxUBC9hJTHpVc130_head.
- NP1180209.RAfSg6JwldkfU3k7LbeHdVxevFZnM9ftLxUBC9hJTHpVc130_assertion description "[High IGF2 and FGFR3 are associated with tumour progression in undifferentiated pleomorphic sarcomas, but EGFR and FGFR3 mutations are a rare event.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1180209.RAfSg6JwldkfU3k7LbeHdVxevFZnM9ftLxUBC9hJTHpVc130_provenance.
- NP1180209.RAfSg6JwldkfU3k7LbeHdVxevFZnM9ftLxUBC9hJTHpVc130_assertion evidence source_evidence_literature NP1180209.RAfSg6JwldkfU3k7LbeHdVxevFZnM9ftLxUBC9hJTHpVc130_provenance.
- NP1180209.RAfSg6JwldkfU3k7LbeHdVxevFZnM9ftLxUBC9hJTHpVc130_assertion SIO_000772 24804818 NP1180209.RAfSg6JwldkfU3k7LbeHdVxevFZnM9ftLxUBC9hJTHpVc130_provenance.
- NP1180209.RAfSg6JwldkfU3k7LbeHdVxevFZnM9ftLxUBC9hJTHpVc130_assertion wasDerivedFrom befree-2016 NP1180209.RAfSg6JwldkfU3k7LbeHdVxevFZnM9ftLxUBC9hJTHpVc130_provenance.
- NP1180209.RAfSg6JwldkfU3k7LbeHdVxevFZnM9ftLxUBC9hJTHpVc130_assertion wasGeneratedBy ECO_0000203 NP1180209.RAfSg6JwldkfU3k7LbeHdVxevFZnM9ftLxUBC9hJTHpVc130_provenance.